Characterization of salivary gland side effects secondary to 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results.
Characterization of salivary gland side effects secondary to 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results.
- 2013
MedStar Washington Hospital Center
Medicine/Nuclear Medicine
MedStar Washington Hospital Center
Medicine/Nuclear Medicine